Physician profile
Paul F Laeseke
NPI 1902030778
$2,895,141.38
in general payments reported to CMS, 2019-2025
8 companies · $2.5M in 2025
The $2.5M reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $53K · 2021: $6,058 · 2022: $16K · 2023: $13K · 2024: $208K · 2025: $2.5M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1.6M · Consulting Fee: $1.1M · Travel and Lodging: $56K · Food and Beverage: $4,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,566,228.70 |
| Consulting Fee | $1,139,907.42 |
| Travel and Lodging | $55,668.73 |
| Food and Beverage | $4,087.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $2,742,099.21 | 2024-2025 | |
| Ethicon Endo-Surgery INC. | $90,442.22 | 2019-2023 | Echelon Endopath, Echelon Flex, Enseal X1 |
| Medical Device Business Services, INC. | $28,265.69 | 2019-2023 | Echelon Flex, Enseal X1, Echelon Circular |
| Ge Healthcare | $20,297.37 | 2023-2025 | |
| Ethicon US, LLC | $11,960.88 | 2019-2023 | Harmonic |
| Ethicon INC. | $1,651.69 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $302.25 | 2020-2023 | Artis Icono Floor |
| Bard Peripheral Vascular, INC. | $122.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Laeseke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.